Unveiling the role of O(6)-methylguanine-DNA methyltransferase in cancer therapy: insights into alkylators, pharmacogenomics, and others.

Cancer chemotherapy is advancing as we understand how cellular mechanisms and drugs interact, particularly involving the enzyme MGMT, which repairs DNA damage that can cause cancer. This review examines MGMT's role in DNA repair, its impact on chemotherapy, and its complex interaction with radiation therapy. MGMT activity can both protect against mutations and cause drug resistance. Modulating MGMT could improve treatment efficacy and tailoring therapy to MGMT status may enhance patient outcomes. Understanding MGMT is crucial for developing precise cancer treatments and advancing patient care.

Detecting High-Energy Neutrinos from Galactic Supernovae with ATLAS.

We show that ATLAS, a collider detector, can measure the flux of high-energy supernova neutrinos, which can be produced from days to months after the explosion. Using Monte Carlo simulations for predicted fluxes, we find at most O(0.1-1) starting events and O(10-100) throughgoing events from a supernova 10 kpc away. Possible Galactic supernovae from Betelgeuse and Eta Carinae are further analyzed as demonstrative examples. We argue that, even with limited statistics, ATLAS has the ability to discriminate among flavors and between neutrinos and antineutrinos, making it a unique neutrino observatory so far unmatched in this capability.